These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 11489822

  • 1. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
    Grotzer MA, Hogarty MD, Janss AJ, Liu X, Zhao H, Eggert A, Sutton LN, Rorke LB, Brodeur GM, Phillips PC.
    Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
    [Abstract] [Full Text] [Related]

  • 2. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
    Grotzer MA, von Hoff K, von Bueren AO, Shalaby T, Hartmann W, Warmuth-Metz M, Emser A, Kortmann RD, Kuehl J, Pietsch T, Rutkowski S.
    Klin Padiatr; 2007 Aug; 219(6):312-7. PubMed ID: 18050040
    [Abstract] [Full Text] [Related]

  • 3. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.
    Grotzer MA, Janss AJ, Phillips PC, Trojanowski JQ.
    Klin Padiatr; 2000 Aug; 212(4):196-9. PubMed ID: 10994550
    [Abstract] [Full Text] [Related]

  • 4. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.
    Rutkowski S, von Bueren A, von Hoff K, Hartmann W, Shalaby T, Deinlein F, Warmuth-Metz M, Soerensen N, Emser A, Bode U, Mittler U, Urban C, Benesch M, Kortmann RD, Schlegel PG, Kuehl J, Pietsch T, Grotzer M.
    Clin Cancer Res; 2007 May 01; 13(9):2651-7. PubMed ID: 17473196
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
    Biegel JA, Janss AJ, Raffel C, Sutton L, Rorke LB, Harper JM, Phillips PC.
    Clin Cancer Res; 1997 Mar 01; 3(3):473-8. PubMed ID: 9815707
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
    Phi JH, Kim JH, Eun KM, Wang KC, Park KH, Choi SA, Kim YY, Park SH, Cho BK, Kim SK.
    J Neurosurg Pediatr; 2010 Jun 01; 5(6):608-14. PubMed ID: 20515335
    [Abstract] [Full Text] [Related]

  • 7. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
    von Hoff K, Hartmann W, von Bueren AO, Gerber NU, Grotzer MA, Pietsch T, Rutkowski S.
    Pediatr Blood Cancer; 2010 Mar 01; 54(3):369-76. PubMed ID: 19908297
    [Abstract] [Full Text] [Related]

  • 8. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system.
    Pietsch T, Scharmann T, Fonatsch C, Schmidt D, Ockler R, Freihoff D, Albrecht S, Wiestler OD, Zeltzer P, Riehm H.
    Cancer Res; 1994 Jun 15; 54(12):3278-87. PubMed ID: 8205550
    [Abstract] [Full Text] [Related]

  • 9. Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays.
    Kagawa N, Maruno M, Suzuki T, Hashiba T, Hashimoto N, Izumoto S, Yoshimine T.
    Brain Tumor Pathol; 2006 Apr 15; 23(1):41-7. PubMed ID: 18095118
    [Abstract] [Full Text] [Related]

  • 10. Correlation of gamma-catenin expression with good prognosis in medulloblastomas.
    Misaki K, Marukawa K, Hayashi Y, Fukusato T, Minamoto T, Hasegawa M, Yamashita J, Fujisawa H.
    J Neurosurg; 2005 Mar 15; 102(2 Suppl):197-206. PubMed ID: 16156230
    [Abstract] [Full Text] [Related]

  • 11. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
    Marchetti D, Mrak RE, Paulsen DD, Sinnappah-Kang ND.
    J Exp Clin Cancer Res; 2007 Mar 15; 26(1):5-23. PubMed ID: 17550129
    [Abstract] [Full Text] [Related]

  • 12. High promoter hypermethylation frequency of p14/ARF in supratentorial PNET but not in medulloblastoma.
    Inda MM, Muñoz J, Coullin P, Fauvet D, Danglot G, Tuñón T, Bernheim A, Castresana JS.
    Histopathology; 2006 Apr 15; 48(5):579-87. PubMed ID: 16623784
    [Abstract] [Full Text] [Related]

  • 13. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.
    Gajjar A, Hernan R, Kocak M, Fuller C, Lee Y, McKinnon PJ, Wallace D, Lau C, Chintagumpala M, Ashley DM, Kellie SJ, Kun L, Gilbertson RJ.
    J Clin Oncol; 2004 Mar 15; 22(6):984-93. PubMed ID: 14970185
    [Abstract] [Full Text] [Related]

  • 14. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma.
    Pingoud-Meier C, Lang D, Janss AJ, Rorke LB, Phillips PC, Shalaby T, Grotzer MA.
    Clin Cancer Res; 2003 Dec 15; 9(17):6401-9. PubMed ID: 14695141
    [Abstract] [Full Text] [Related]

  • 15. hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors.
    Fan X, Wang Y, Kratz J, Brat DJ, Robitaille Y, Moghrabi A, Perlman EJ, Dang CV, Burger PC, Eberhart CG.
    Am J Pathol; 2003 Jun 15; 162(6):1763-9. PubMed ID: 12759234
    [Abstract] [Full Text] [Related]

  • 16. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
    Takei H, Nguyen Y, Mehta V, Chintagumpala M, Dauser RC, Adesina AM.
    J Neurosurg Pediatr; 2009 Jan 15; 3(1):61-5. PubMed ID: 19119907
    [Abstract] [Full Text] [Related]

  • 17. TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors.
    Grotzer MA, Janss AJ, Fung K, Biegel JA, Sutton LN, Rorke LB, Zhao H, Cnaan A, Phillips PC, Lee VM, Trojanowski JQ.
    J Clin Oncol; 2000 Mar 15; 18(5):1027-35. PubMed ID: 10694553
    [Abstract] [Full Text] [Related]

  • 18. [Expression of the neurotrophin-receptor TrkB predicts outcome in nephroblastomas: results of a pilot-study].
    Eggert A, Grotzer MA, Zhao H, Brodeur GM, Evans AE.
    Klin Padiatr; 2001 Mar 15; 213(4):191-6. PubMed ID: 11528553
    [Abstract] [Full Text] [Related]

  • 19. An immunohistochemical analysis of medulloblastoma and PNET with emphasis on N-myc protein expression.
    Moriuchi S, Shimizu K, Miyao Y, Hayakawa T.
    Anticancer Res; 1996 Mar 15; 16(5A):2687-92. PubMed ID: 8917371
    [Abstract] [Full Text] [Related]

  • 20. Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon.
    Frühwald MC, O'Dorisio MS, Rush LJ, Reiter JL, Smiraglia DJ, Wenger G, Costello JF, White PS, Krahe R, Brodeur GM, Plass C.
    J Med Genet; 2000 Jul 15; 37(7):501-9. PubMed ID: 10882752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.